Jazz Pharmaceuticals plc — Director's Dealing 2014

Feb 27, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2014-02-26

Reporting Person: FALBERG KATHRYN E (EVP and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-26	Ordinary Shares	M	10204	$7.35	Acquired	134925	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-26	Incentive Stock Option (right to buy)	$7.35	M	10204	Disposed	2019-12-06	Ordinary Shares (10204)	Direct

Footnotes

F1: The ordinary shares subject to this option fully vested as of December 1, 2013.